BlackRock Institutional Trust’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $461M | Buy |
12,724,714
+12,577,643
| +8,552% | +$456M | 0.07% | 287 |
|
|
2016
Q3 | $6.77M | Sell |
147,071
-38,450
| -21% | -$1.77M | ﹤0.01% | 2564 |
|
|
2016
Q2 | $9.32M | Buy |
185,521
+9,000
| +5% | +$452K | ﹤0.01% | 2326 |
|
|
2016
Q1 | $9.45M | Buy |
176,521
+3,190
| +2% | +$171K | ﹤0.01% | 2287 |
|
|
2015
Q4 | $11.4M | Buy |
173,331
+31,494
| +22% | +$2.07M | ﹤0.01% | 2238 |
|
|
2015
Q3 | $8.01M | Sell |
141,837
-90,148
| -39% | -$5.09M | ﹤0.01% | 2434 |
|
|
2015
Q2 | $13.7M | Sell |
231,985
-238,721
| -51% | -$14.1M | ﹤0.01% | 2180 |
|
|
2015
Q1 | $29.3M | Buy |
470,706
+267,610
| +132% | +$16.7M | ﹤0.01% | 1685 |
|
|
2014
Q4 | $11.7M | Buy |
203,096
+64,987
| +47% | +$3.74M | ﹤0.01% | 2274 |
|
|
2014
Q3 | $7.42M | Buy |
138,109
+31,596
| +30% | +$1.7M | ﹤0.01% | 2487 |
|
|
2014
Q2 | $5.58M | Buy |
106,513
+6,701
| +7% | +$351K | ﹤0.01% | 2734 |
|
|
2014
Q1 | $5.27M | Buy |
99,812
+38,512
| +63% | +$2.03M | ﹤0.01% | 2759 |
|
|
2013
Q4 | $2.46M | Sell |
61,300
-33,941
| -36% | -$1.36M | ﹤0.01% | 3074 |
|
|
2013
Q3 | $3.6M | Sell |
95,241
-211,882
| -69% | -$8M | ﹤0.01% | 2873 |
|
|
2013
Q2 | $12M | Buy |
+307,123
| New | +$12M | ﹤0.01% | 2189 |
|